WATERTOWN, Mass.--(BUSINESS WIRE)--Enanta Pharmaceuticals, Inc., (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs in the infectious disease field, today announced that it was selected for addition to the NASDAQ Biotechnology Index (NASDAQ:NBI). NASDAQ has announced that the annual re-ranking of the NASDAQ Biotechnology Index will become effective upon market open on December 22, 2014.
Help employers find you! Check out all the jobs and post your resume.
